1. The department shall provide coverage, subject to state and federal appropriations, for the full cost of amino acid-based elemental formulas, meaning formulas made from single nonallergenic amino acids, for children under nineteen years of age with a medical diagnosis of immunoglobulin E and nonimmunoglobulin E mediated allergies to multiple food proteins, food protein-induced enterocolitis syndrome, eosinophilic disorders, and impaired absorption of nutrients caused by disorders affecting the absorptive surface, functional length, and motility of the gastrointestinal tract.
1. Yu H, et al. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal. 1999;13:166–172.
2. Hong Y, et al. Quantitative genetic analyses of insulin-like growth factor-I (IGF-I), IGF-binding protein-1 and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab. 1996;81:1791–1797.
3. Harrela M, et al. Genetic and environmental components of inter-individual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J Clin Invest. 1996;98:2612–1615.
4. Livingstone C. Insulin-like growth factor-I (IGF-I) and clinical nutrition. Clinical Science. 2013;125: 265–280.
5. Clemmons DR,et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab. 1981;53:1247–1250.
6. Gomez JM, et al. The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res. 2004;14:91–96.
7. Hintz RL, et al. Plasma somatomedin and growth hormone values in children with protein calorie malnutrition. J ;92:153–156.
8. Hill K, et al. Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa. J Am Coll ;12:475–478.
9. Miell JP, et al. Effects of hypothyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab. 1993;76:950–955.
10. Clemmons DR. Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol Metab. 2009;20:349–356.
11. Goldspink G. Loss of muscle strength during aging studied at the gene level. Rejuvenation Res. 2007;10:397–405.
12. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev. 2004;84:649–698.
13. Lorda-Diez CI, et al. Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme. J Biol Chem. 2009;284:29988–29996.
14. Murchison ND, et al. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development. 2007;134:2697–2708.
15. Pryce BA, et al. Recruitment and maintenance of tendon progenitors by TGFβ signaling are essential for tendon formation. Development. 2009; 136:1351–1361.
16. Heinemeier K, et al. Role of TGF-β1 in relation to exercise-induced type I collagen synthesis in human tendinous tissue. J Appl Physiol2 2003;95:2390–2397.
17. Holladay C, et al. Preferential tendon stem cell response to growth factor supplementation. J Tissue Eng Regen Med. 2014 Jan 29. doi: /. [Epub ahead of print]
Elemental BHB Keto is an exogenous ketone supplement with the main ingredient of beta-hydroxybutyrate (goBHB™), a ketone salt, that has been shown in studies to induce a state of ketosis in under 30 minutes. This state provides clean hightened energy, rapid fat loss, enhanced brain function, regulated blood sugar levels, improved insulin sensitivity, lower body inflammation & appetite suppression. Elemental BHB Keto fuel with nothing artificial will optimise your low carbohydrate or ketogenic lifestyle by providing the fastest way to ketosis.